Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

EU support of new technologies to increase plant productivity - 5 Million Euro for plant breeding

18.02.2016

A continuous growth of the world population leads to new challenges for agriculture. A new green revolution seems to be mandatory to improve crop yield in the future. Following this prospect, the EU program FET Open has decided to support a research project that aim at developing new technologies of increasing plant productivity with 5 Million Euros. This research project is coordinated by Dr. Arren Bar-Even, research group leader at the Max Planck Institute of Molecular Plant Physiology in Potsdam-Golm.

In the face of an increasing global population the productivity of agriculture needs to be considerably improved. However, traditional plant breeding techniques are reaching their limits. Therefore, out-of-the-box solutions are required to support a new green revolution. Dr. Arren Bar-Even and five partners from academia and industry peruse new approaches to employ synthetic biology tools in the aim to re-wire plant metabolism and enhance their growth rate and yield.

The 5-years project “FutureAgriculture” is funded with 5 Million Euro by the European Commission. The FET Open program supports the development of new unconventional and visionary ideas with long-term potential. This allows the identification of promising henceforth research areas. In the current application period 12 out of 670 submitted projects were selected for funding.

Dr. Arren Bar-Even’s team at the Max Planck Institute of Molecular Plant Physiology and his research partners will work on improving the yield and rate of carbon fixation in plants, which is often the limiting part of photosynthesis. Specifically, the team will focus on a process termed photorespiration, in which energy is lost and fixed carbon is released, thereby limiting plant growth. By evolving new enzyme chemistries, the scientists aim at engineering new pathways that avoid the negative effects of photorespiration.

The research project is structured into four phases. First, promising candidate pathways will be identified by computer analysis and modeling. The most effective pathways – the shortest and most energy-saving ones – will be evolved and constructed in test tubes. Next, the pathways will be integrated in single-cell bacteria and algae. For this purpose, Echerichia coli and Chlamydomonas, two model organisms in biology, will be used. In the last phase the most efficient pathways will be introduced into higher plants, followed by a detailed analysis and characterization.

This interdisciplinary project started at January 1st, 2016. Dr. Arren Bar-Even is coordinator of the project. The other partners involved are Dr. Tobias Erb (Max Planck Institute of Terrestrial Microbiology / SYNMIKRO, Germany), Dr. Patrik Jones (Imperial College London, UK) and Prof. Dan Tawfik (Weizmann Institute of Science, Israel), as well as two companies, Evogene (Israel) and IN S.r.l. (Italy).

The Max Planck Institutes
The two Max Planck Institutes belong to the Max Planck Society, Germany's most successful research organization in the field of basic research.
The Max Planck Institute of Molecular Plant Physiology investigates metabolic and molecular processes at different levels in plants. The overall goal is to understand how metabolism and growth are regulated and to learn how they respond to different factors.
The mission of the Max Planck Institute for Terrestrial Microbiology is to understand how microorganisms function at the molecular, cellular, and community level. At the Center of Synthetic Microbiology (SYNMIKRO), synthetic biology approaches are used to understand and engineer microorganisms.

The Imperial College London
Imperial College London is a science-based university. The Faculty of Natural Sciences research strategy is to meet the changing needs of society, industry and healthcare, and to address the global challenges of climate change, energy, global health and security.

The Weizmann Institute of Science
The Weizmann Institute of Science is one of the world’s leading multidisciplinary basic research institutions in the natural and exact sciences. The Faculty of Biochemistry research focuses on the processes of life at the levels of molecules, cells, organs, organisms and ecosystems.

Evogene
Evogene is specialized in improving plant traits through applying biotechnology and advanced breeding for a wide variety of crops. Their main focus is on the discovery of genes, linked to traits, such as improved yield and drought tolerance.

IN S.r.l.
IN S.r.l. is an agency whose mission is to support private and public organizations in participating in EU, national and local innovation projects and to provide professional project management services.

Contact:
Dr. Arren Bar-Even
Max Planck Institute of Molecular Plant Physiology
Tel. 0331/567 8910
Bar-Even@mpimp-golm.mpg.de

Dr. Ulrike Glaubitz
Press and public relations
Max Planck Institute of Molecular Plant Physiology
Tel. 0331/567 8275
Glaubitz@mpimp-golm.mpg.de
http://www.mpimp-golm.mpg.de

Weitere Informationen:

http://www.mpimp-golm.mpg.de/2046051/FETOpen_Arren_Bar-Even

Dipl. Ing. agr. Ursula Ross-Stitt | Max-Planck-Institut für Molekulare Pflanzenphysiologie

Weitere Nachrichten aus der Kategorie Förderungen Preise:

nachricht Eine Milliarde Euro für die Hochschulmedizin
17.02.2017 | Deutsche Hochschulmedizin e.V.

nachricht Sensible Daten besser analysieren
16.02.2017 | Georg-August-Universität Göttingen

Alle Nachrichten aus der Kategorie: Förderungen Preise >>>

Die aktuellsten Pressemeldungen zum Suchbegriff Innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Innovative Antikörper für die Tumortherapie

Immuntherapie mit Antikörpern stellt heute für viele Krebspatienten einen Erfolg versprechenden Ansatz dar. Weil aber längst nicht alle Patienten nachhaltig von diesen teuren Medikamenten profitieren, wird intensiv an deren Verbesserung gearbeitet. Forschern um Prof. Thomas Valerius an der Christian Albrechts Universität Kiel gelang es nun, innovative Antikörper mit verbesserter Wirkung zu entwickeln.

Immuntherapie mit Antikörpern stellt heute für viele Krebspatienten einen Erfolg versprechenden Ansatz dar. Weil aber längst nicht alle Patienten nachhaltig...

Im Focus: Durchbruch mit einer Kette aus Goldatomen

Einem internationalen Physikerteam mit Konstanzer Beteiligung gelang im Bereich der Nanophysik ein entscheidender Durchbruch zum besseren Verständnis des Wärmetransportes

Einem internationalen Physikerteam mit Konstanzer Beteiligung gelang im Bereich der Nanophysik ein entscheidender Durchbruch zum besseren Verständnis des...

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: Hoch wirksamer Malaria-Impfstoff erfolgreich getestet

Tübinger Wissenschaftler erreichen Impfschutz von bis zu 100 Prozent – Lebendimpfstoff unter kontrollierten Bedingungen eingesetzt

Tübinger Wissenschaftler erreichen Impfschutz von bis zu 100 Prozent – Lebendimpfstoff unter kontrollierten Bedingungen eingesetzt

Im Focus: Sensoren mit Adlerblick

Stuttgarter Forscher stellen extrem leistungsfähiges Linsensystem her

Adleraugen sind extrem scharf und sehen sowohl nach vorne, als auch zur Seite gut – Eigenschaften, die man auch beim autonomen Fahren gerne hätte. Physiker der...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

Die Welt der keramischen Werkstoffe - 4. März 2017

20.02.2017 | Veranstaltungen

Schwerstverletzungen verstehen und heilen

20.02.2017 | Veranstaltungen

ANIM in Wien mit 1.330 Teilnehmern gestartet

17.02.2017 | Veranstaltungen

 
VideoLinks
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

Innovative Antikörper für die Tumortherapie

20.02.2017 | Medizin Gesundheit

Multikristalline Siliciumsolarzelle mit 21,9 % Wirkungsgrad – Weltrekord zurück am Fraunhofer ISE

20.02.2017 | Energie und Elektrotechnik

Wie Viren ihren Lebenszyklus mit begrenzten Mitteln effektiv sicherstellen

20.02.2017 | Biowissenschaften Chemie